Richeldi, Luca <br/><br/>
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.  [electronic resource] 

 -  The New England journal of medicine  Sep 2011 
 - 1079-87 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1103690  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alanine Transaminase--blood<br/>Aspartate Aminotransferases--blood<br/>Enzyme Inhibitors--adverse effects<br/>Female<br/>Humans<br/>Idiopathic Pulmonary Fibrosis--drug therapy<br/>Indoles--adverse effects<br/>Liver--drug effects<br/>Male<br/>Middle Aged<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Vital Capacity